SNYR (Synergy CHC) Short-Term Debt to Capital

Corporate company logo of Synergy CHC Corp. (SNYR)

Synergy CHC Corp (SNYR) is developing a strategy of acquiring forgotten niche cosmetics and dietary supplement brands for subsequent relaunch, integrating AI into e-commerce and logistics to drive growth without expanding headcount. This price chart reflects a value of 0.00. The holding company is based in the US, leveraging a diversified portfolio of beauty and health products promoted through retail networks via digital marketing.

Ratio of Short-Term Indebtedness to Capital: synergychc.com (SNYR) for 10/24/2024 - 10/03/2026
Brand item of synergychc.com

This ratio measures the share of short-term borrowings within the equity structure, determining the company's dependence on the operational refinancing of liabilities. By analyzing this chart of short-term liabilities to equity, an investor can assess how effectively the stable cash flows from the consumer staples sales of Synergy CHC Corp (SNYR) cover current loans without compromising the holding's long-term development.

Competitors of Synergy CHC Corp (SNYR)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Short-Term Debt to Capital Coefficient Invizyne Technologies (EXOZ)|ORMP: Short-Term Debt to Equity Ratio|Current Liabilities to Capital Entera Bio Ltd.|MindWalk Holdings (HYFT) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ABVC|CPIX (Cumberland Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Quantum BioPharma Ltd. QNTM|Short-Term Debt to Equity FibroGen Corp (FGEN)|TELO (Telomir Pharmaceuticals Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RANI (Rani Therapeutics Holdings, Inc.)|Short-Term Indebtedness to Equity Rallybio Corp|LEXX: Short-Term Debt to Equity Ratio|Current Liabilities to Capital Pulmatrix Inc|PTHL (ftzy.com.cn) - Short-Term Debt to Equity Ratio|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio impactbiomedinc.com (IBO)|Short-Term Debt to Capital TNFA|YCBD (cbdmd.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital PRFX (PainReform Limited)|CYTO - Short-Term Debt to Equity Ratio|LIPO: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OPTN (optinose.com)|PIRS: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Procaps Group|Short-Term Debt to Equity Petros|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Ratio of Short-Term Indebtedness to Capital